Yervoy Solution For Injection 5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

YERVOY: Solution for injection (5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

IPILIMUMAB (IP i LIM ue mab) is a monoclonal antibody. It is used to treat melanoma, a type of skin cancer.

In-Depth Information
Select a Medication

YERVOY 200mg/40ml Solution for Injection

NDC: 000032328
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Malignant Melanoma

Storage Information
Diluted product is stable and sterile for 24 hours when stored refrigerated or at room temperature
Refrigerate (between 36 and 46 degrees F)
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Do not freeze
Discard unused portion. Do not store for later use.
YERVOY 200mg/40ml Solution for Injection

Reported Side Effects for YERVOY 200mg/40ml Solution for Injection

Hives Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Eye Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Brain Dysfunction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.3%*
Severity: SEVERE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<0.4%*
Severity: SEVERE
Onset: EARLY
Infusion-related Reactions Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Eosinophilia Incidence:
<2.1%*
Severity: SEVERE
Onset: DELAYED
Deafness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Amylase Levels Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Weakness Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Weight Loss Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<0.2%*
Severity: SEVERE
Onset: EARLY
Acute Lung Injury Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Low Steroid Hormones Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Inflamed Eyes Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Cushing's Syndrome Incidence:
<0.2%*
Severity: MODERATE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Throat Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Guillain-Barre Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
<0.8%*
Severity: SEVERE
Onset: EARLY
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Bilirubin Level Incidence:
<1.5%*
Severity: SEVERE
Onset: DELAYED
Psoriasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<2.3%*
Severity: SEVERE
Onset: RAPID
Inflamed Heart Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Eye Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Heart Muscle Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Inflamed Iris (Eye) Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Underactive Thyroid Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
0.2%*
Severity: SEVERE
Onset: DELAYED
Lung Inflammation Incidence:
0.2-1.0%*
Severity: SEVERE
Onset: DELAYED
Overactive Thyroid Incidence:
0.2-0.6%*
Severity: SEVERE
Onset: DELAYED
Brain Infection Incidence:
0.4-1.0%*
Severity: SEVERE
Onset: DELAYED
Hypopituitarism Incidence:
1.0-7.4%*
Severity: SEVERE
Onset: DELAYED
Hole In Intestines Incidence:
1.0-1.5%*
Severity: SEVERE
Onset: DELAYED
Antibody Formation Incidence:
1.1-4.9%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
2.0-2.1%*
Severity: SEVERE
Onset: EARLY
Tired Incidence:
2.3-7.0%*
Severity: SEVERE
Onset: EARLY
Inflamed Colon Incidence:
3.0-8.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Intestine Incidence:
5.0-14.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
9.0-10.0%*
Severity: SEVERE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with YERVOY

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5